Contract HHSF223201710392P
Repligen Corporation · Department Of Health And Human Services · September 25, 2017
Repligen Corporation was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 25, 2017 for $21,000 of work in biological product (except diagnostic) manufacturing. Performance is in Silver Spring, MD. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSF223201710392P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Quality Control- Instruments And Laboratory Equipment
- Place of performance
- Silver Spring, MD
- First action
- September 25, 2017
Description
IGF::CL::IGF ATF PARTS AND CONSUMABLES
Modification timeline
-
September 25, 2017Base award$20.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSF223201710392P?
Contract HHSF223201710392P is a federal contract awarded to Repligen Corporation by Department Of Health And Human Services on September 25, 2017 for $21,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSF223201710392P?
Repligen Corporation won contract HHSF223201710392P from Department Of Health And Human Services.
How much is contract HHSF223201710392P worth?
Contract HHSF223201710392P has obligated $21,000 to date.